Nebulizer in Russian

The Skolkovo innovation center ended with a two -day Startup Village conference, during which 247 innovative projects from Russia and other countries were presented. We talked with the head of the company "VKM Group" Sergei Agafonov about their project to develop and manufacture a qualitatively new model of the nebulizer medical device.

The Nebulizer project called Divo was presented at the healthcare session "Breakthrough Technologies in Medicine." The company "VKM Group" is a resident of the cluster of energy -efficient technologies Skolkovo, and this project demonstrates one of several areas of its activities.

A nebulizer is a device for creating and entering the aerosol of the medicine into the respiratory tract. The uniqueness of Divo Nebulizer lies, firstly, in the use of patented technology of vortex spraying, and secondly, in a high level of dispersion of drugs. It is the size of the particle of the drug that is an indicator of the quality of the nebulizer: it is believed that the smaller they are, the stronger the therapeutic effect and the result is achieved faster. The sprayed drug easily enters all parts of the respiratory system and immediately begins to affect the focus of the disease directly.

In the case of each specific disease, it is necessary to affect different parts of the respiratory system: directly on the lungs, on the middle and upper respiratory tract. Our development allows you to regulate the effect of exposure depending on the task of treatment.

A nebulizer is a means of delivering drugs in the treatment of the main groups of diseases of the population, among which two -thirds are infectious and parasitic diseases and tuberculosis. This also includes diseases of the respiratory system, digestion, nervous system and many others.

The advantage of Divo Nebulizer is a unique technological solution that allows you to spray various drugs with the same device, including powdered and oil -based. That is, in the family it is enough to have one Divo Nebulizer in order to treat any infectious diseases and respiratory systems, if necessary, to treat. “We produce our product on the existing market. Nebulizers are quite widely known, if not in our country, then in America, in Europe they are very popular and widespread, because this is an effective way to deliver the medicine to the place of inflammation, ”the project manager Sergei Agafonov explains the relevance of development.

The technological novelty is designed to optimize the use of various drugs acting on the respiratory organs for each disease, starting with infectious and ending with blood circulation diseases, there are special drugs that have an effect with a certain dose and effects on this body system. The development of a company can help a breakthrough in medicine if it becomes an impetus for the appearance of new drugs designed for delivery to the body using a nebulizer.

“Until now, treatment has been widespread in our country when they breathe over a bowl with a towel, but this is an archaic method. Not with all diseases, you can use warming, a steam bath is also not always useful, and there are no almost useful substances in a couple. Comparing a nebulizer with such treatment is the same as comparing a modern car with a body, ”says Sergey Agafonov.

To the question of why not selling this technology to other companies, the project manager recalls that this development takes place according to the state program for the development of the domestic medical industry, so they will be focused primarily on the Russian market. In addition, this is not necessary: ​​“We are able to produce this device ourselves, it is not so complicated. Other companies produce exactly the same products, they all have the same compressors suppliers and the same principle of operation. We position ourselves as manufacturers of high -quality, functional products. ”

The price of goods expected at this stage is the average market, not the lowest, but not very high, somewhere around 2-3 thousand rubles. “At this average price, the price, if we compare with the automobile market,“ Zhiguli ”, we are going to sell Mercedes,” promises Agafonov.

The development of Divo is the nebulizer is already completed. Pre -owned models were released. It remains to register the product, certification of production and begin to commercialize the project.

The name of the device was not chosen by chance: Divo sounds like [marvelous], that is, a miracle: “This is such a good Russian word, denoting what causes surprise, a miracle. We chose the name specifically for this project in the field of healthcare, ”the entrepreneur explains.

The design of the nebulizer at the stage of preparation for production has already been developed, but has not yet been patented and therefore is not disclosed by a wide audience. The market requirements dictated to the project the conditions according to which two design options were developed at once: standard and children's, more vivid and attractive for kids.

It is planned to launch two types of nebulizer: one for domestic use - it is more easy to manage and is designed for independent use, the other for professional use. It has a more complex management system and is designed for medical enterprises: it is equipped with a small built -in computer, with which you can install, for example, the type of medicine, its amount and time of the procedure, so such an apparatus will be much more expensive. “The nebulizer for home use differs from others, in that it will be equipped with four chambers for drugs. There is no one yet. One camera, like everyone else, sprays the same drugs, but the dispersion is smaller, and therefore the therapeutic effect is higher. Three additional cameras are designed for oily solutions, for powdered drugs and for the use of decoctions, ”says Sergey Agafonov.

The company's plans are not limited to one device: “We are creating a new brand of medical equipment that we want to continue to promote. Already now, other devices are being developed in parallel, which we are going to implement in the future under the Divo brand, ”Sergey Agafonov notes not without pride.

According to the entrepreneur, the project is significant for him and by virtue of a social orientation: “Frankly, it’s nice to do some kind of commercial project in which there is a social thought. It somehow supports, you understand that you are doing a business that is useful not only for you, but also for other people. ”

The launch of the production of the Nebulizer Divo is scheduled for the end of the year. Now, in order to implement this plan, the company is engaged in the search for an investor.